Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease
Hirotaka Shoji(Fujita Health University), Tatsuya Kanto(National Center for Global Health and Medicine), Takuji Torimura(Omuta hospital), Hideyuki Hyogo(Albert Einstein College of Medicine), Sachiyo Yoshio(National Center for Global Health and Medicine), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), Erina Kumagai(National Center for Global Health and Medicine), Yoichi Hiasa(Ehime University Hospital), Yohei Mano(National Center for Global Health and Medicine), Hiroshi Aikata(Hiroshima Prefectural Hospital), Moto Fukai(Hokkaido University), Tomohiko Ohashi(Aichi Medical University), Masaya Sugiyama(National Center for Global Health and Medicine), Kiyoaki Ito(Aichi Medical University), Yuichi Nozaki(National Center for Global Health and Medicine), Masanori Abe(Ehime University), Masanori Atsukawa(Nippon Medical School), Toshiya Kamiyama(Hokkaido University), Akinobu Taketomi(Hokkaido University), Takumi Kawaguchi(Kurume University), Masaaki Korenaga(National Center for Global Health and Medicine), Taeang Arai(Nippon Medical School), Masashi Yoneda(Aichi Medical University), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Norio Itokawa(Chiba Hokusou Hospital)
Cited by 64
Related Papers
Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *
|Hepatology|2005|1.5k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614